RVLP Annual Total Long Term Liabilities
$57.69 M
+$9.87 M+20.63%
31 December 2022
Summary:
As of February 5, 2025, RVLP annual total long term liabilities is $57.69 million, with the most recent change of +$9.87 million (+20.63%) on December 31, 2022. During the last 3 years, it has fallen by -$214.92 million (-78.84%).RVLP Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
RVLP Quarterly Long Term Liabilities
$686.00 K
-$54.01 M-98.75%
30 June 2023
Summary:
As of February 5, 2025, RVLP quarterly total long term liabilities is $686.00 thousand, with the most recent change of -$54.01 million (-98.75%) on June 30, 2023. Over the past year, it has dropped by -$47.08 million (-98.56%).RVLP Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
RVLP Long Term Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +20.6% | -98.6% |
| 3 y3 years | -78.8% | -99.8% |
| 5 y5 years | -83.9% | -99.8% |
RVLP Long Term Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | ||||
| 5 y | 5-year | ||||
| alltime | all time | -85.4% | -99.8% |
RVL Pharmaceuticals Long Term Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| June 2023 | - | $686.00 K(-98.7%) |
| Mar 2023 | - | $54.70 M(-5.2%) |
| Dec 2022 | $57.69 M(+20.6%) | $57.69 M(-11.7%) |
| Sept 2022 | - | $65.33 M(+36.8%) |
| June 2022 | - | $47.76 M(-10.8%) |
| Mar 2022 | - | $53.53 M(+11.9%) |
| Dec 2021 | $47.83 M(-78.4%) | $47.83 M(+5416.6%) |
| Sept 2021 | - | $867.00 K(-17.1%) |
| June 2021 | - | $1.05 M(-99.5%) |
| Mar 2021 | - | $221.32 M(+0.0%) |
| Dec 2020 | $221.31 M | $221.31 M(-0.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2020 | - | $221.61 M(-18.8%) |
| June 2020 | - | $272.90 M(-0.1%) |
| Mar 2020 | - | $273.24 M(+0.2%) |
| Dec 2019 | $272.61 M(-8.5%) | $272.61 M(-0.5%) |
| Sept 2019 | - | $273.89 M(-4.9%) |
| June 2019 | - | $288.02 M(-3.5%) |
| Mar 2019 | - | $298.42 M(+0.2%) |
| Dec 2018 | $297.78 M(-17.1%) | $297.78 M(-8.2%) |
| Sept 2018 | - | $324.36 M(-0.5%) |
| June 2018 | - | $325.84 M(-9.3%) |
| Dec 2017 | $359.28 M(-9.1%) | $359.28 M |
| Dec 2016 | $395.46 M | - |
FAQ
- What is RVL Pharmaceuticals annual total long term liabilities?
- What is the all time high annual total long term liabilities for RVL Pharmaceuticals?
- What is RVL Pharmaceuticals annual total long term liabilities year-on-year change?
- What is RVL Pharmaceuticals quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for RVL Pharmaceuticals?
- What is RVL Pharmaceuticals quarterly long term liabilities year-on-year change?
What is RVL Pharmaceuticals annual total long term liabilities?
The current annual total long term liabilities of RVLP is $57.69 M
What is the all time high annual total long term liabilities for RVL Pharmaceuticals?
RVL Pharmaceuticals all-time high annual total long term liabilities is $395.46 M
What is RVL Pharmaceuticals annual total long term liabilities year-on-year change?
Over the past year, RVLP annual total long term liabilities has changed by +$9.87 M (+20.63%)
What is RVL Pharmaceuticals quarterly total long term liabilities?
The current quarterly long term liabilities of RVLP is $686.00 K
What is the all time high quarterly long term liabilities for RVL Pharmaceuticals?
RVL Pharmaceuticals all-time high quarterly total long term liabilities is $359.28 M
What is RVL Pharmaceuticals quarterly long term liabilities year-on-year change?
Over the past year, RVLP quarterly total long term liabilities has changed by -$47.08 M (-98.56%)